Analyst Ratings For Aptose Biosciences Inc (NASDAQ:APTO)
Today, HC Wainwright set its price target on Aptose Biosciences Inc (NASDAQ:APTO) to $9.00 per share.
There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Aptose Biosciences Inc (NASDAQ:APTO) is Buy with a consensus target price of $6.6667 per share, a potential 191.50% upside.
Some recent analyst ratings include
- 11/16/2018-Aptose Biosciences Inc (NASDAQ:APTO) has coverage initiated with a Buy ➝ Buy rating and $5.00 price target
- 6/8/2017-Aptose Biosciences Inc (NASDAQ:APTO) has coverage initiated with a Neutral ➝ Neutral rating
Recent Trading Activity for Aptose Biosciences Inc (NASDAQ:APTO)
Shares of Aptose Biosciences Inc closed the previous trading session at 2,29 +0,080 3,62 % with 97500 shares trading hands.